The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation

British Journal of Haematology

Volumn 149, Issue 1, 2010, Pages 101-110

  Wang, Zejing ^a   Sorror, Mohamed L ^a,b   Leisenring, Wendy ^a,c   Schoch, Gary ^a   Maloney, David G ^a,b   Sandmaier, Brenda M ^a,b   Storb, Rainer ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

ABO incompatibility; Allogeneic haematopoietic cell transplantation; Nonmyeloablative conditioning; Transfusion

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; HEMAGGLUTININ; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD GROUP ABO INCOMPATIBILITY; CANCER MORTALITY; CANCER PATIENT; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CHRONIC GRAFT REJECTION; CHRONIC LEUKEMIA; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; INFANT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NONMYELOABLATIVE CONDITIONING; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; THROMBOCYTE TRANSFUSION; WHOLE BODY RADIATION;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; BLOOD COMPONENT TRANSFUSION; BLOOD GROUP INCOMPATIBILITY; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE TRANSFUSION; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MIDDLE AGED; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING;

EID: 77949440114     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08073.x     Document Type: Article

References (36)

1. Anasetti, C., Amos, D., Beatty, P.G., Appelbaum, F.R., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Martin, P.J., Mickelson, E., Nisperos, B., O'Quigley, J., Ramberg, R., Sanders, J.E., Stewart, P., Storb, R., Sullivan, K.M., Witherspoon, R.P., Thomas, E.D. & Hansen, J.A. (1989) Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. New England Journal of Medicine, 320, 197-204.
2. Badros, A., Tricot, G., Toor, A., Morris, C., Guo, C., Munshi, N., Barlogie, B. & Cottler-Fox, M. (2002) ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning. Transfusion, 42, 205-209.
3. Baron, F., Vanstraelen, G. & Beguin, Y. (2006) Transfusions after nonmyeloablative or reduced-intensity conditioning regimens. Leukemia, 20, 2081-2086.
4. Benjamin, R.J., McGurk, S., Ralston, M.S., Churchill, W.H. & Antin, J.H. (1999) ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion, 39, 179-187.
5. Bolan, C.D., Childs, R.W., Procter, J.L., Barrett, A.J. & Leitman, S.F. (2001a) Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. British Journal of Haematology, 112, 787-795.
6. Bolan, C.D., Leitman, S.F., Griffith, L.M., Wesley, R.A., Procter, J.L., Stroncek, D.F., Barrett, A.J. & Childs, R.W. (2001b) Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood, 98, 1687-1694.
7. Buckner, C.D., Clift, R.A., Sanders, J.E., Williams, B., Gray, M., Storb, R. & Thomas, E.D. (1978) ABO-incompatible marrow transplants. Transplantation, 26, 233-238.
8. Canals, C., Muniz-Diaz, E., Martinez, C., Martino, R., Moreno, I., Ramos, A., Arilla, M., Boto, N., Pastoret, C., Remacha, A., Sierra, J. & Madoz, P. (2004) Impact of ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion, 44, 1603-1611.
9. Carella, A.M., Cavaliere, M., Corsetti, M.T. & Lerma, E. (2000) Allografting with immunosuppressive conditioning of low-dose fludarabine-cyclophosphamide after autografting. Blood, 96 (Part 1), 553a, #2376. (Abstract).
10. Chien, J.W., Maris, M.B., Sandmaier, B.M., Maloney, D.G., Storb, R.F. & Clark, J.G. (2005) Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 11, 288-296.
11. Curtis, B.R. & McFarland, J.G. (2009) Platelet immunology and alloimmunization. In: Rossi's Principles of Transfusion Medicine (ed. by T.L. Simon, E.L. Snyder, B.G. Solheim, C.P. Stowell, R.G. Strauss & M. Petrides), p. 168. Blackwell Publishing Ltd, Oxford, UK.
12. Diaconescu, R., Flowers, C.R., Storer, B., Sorror, M.L., Maris, M.B., Maloney, D.G., Sandmaier, B.M. & Storb, R. (2004) Morbidity and mortality with nonmyeloablative compared to myeloablative conditioning before hematopoietic cell transplantation from HLA matched related donors. Blood, 104, 1550-1558.
13. Goldman, J., Liesveld, J., Nichols, D., Heal, J. & Blumberg, N. (2003) ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation. Leukemia Research, 27, 489-491.
14. Griffith, L.M., McCoy, Jr, J.P., Bolan, C.D., Stroncek, D.F., Pickett, A.C., Linton, G.F., Lundqvist, A., Srinivasan, R., Leitman, S.F. & Childs, R.W. (2005) Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation. British Journal of Haematology, 128, 668-675.
15. Hogan, W.J., Maris, M., Storer, B., Sandmaier, B.M., Maloney, D.G., Schoch, H.G., Woolfrey, A.E., Shulman, H.M., Storb, R. & McDonald, G.B. (2004) Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients. Blood, 103, 78-84.
16. Ivanov, V., Faucher, C., Mohty, M., Bilger, K., Ladaique, P., Sainty, D., Arnoulet, C., Chabannon, C., Vey, N., Camerlo, J., Bouabdallah, R., Maraninchi,D.,Bardou,V.J.&Blaise,D.(2004) Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level. Transfusion, 44, 501-508.
17. Junghanss, C., Marr, K.A., Carter, R.A., Sandmaier, B.M., Maris, M.B., Maloney, D.G., Chauncey, T., McSweeney, P.A. & Storb, R. (2002) Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biology of Blood and Marrow Transplantation, 8, 512-520.
18. Kalbfleisch, J.D. & Prentice, R.L. (1980) The Statistical Analysis of Failure Time Data. John Wiley & Sons, New York.
19. Keever-Taylor, C.A., Bredeson, C., Loberiza, F.R., Casper, J.T., Lawton, C., Rizzo, D., Burns, W.H., Margolis, D.A., Vesole, D.H., Horowitz, M., Zhang, M.J., Juckett, M. & Drobyski, W.R. (2001) Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biology of Blood and Marrow Transplantation, 7, 620-630.
20. Klumpp, T.R., Herman, J.H., Ulicny, J., Emmons, R.V., Martin, M.E. & Mangan, K.F. (2006) Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 38, 615-620.
21. Le Blanc, K., Remberger, M., Uzunel, M., Mattsson, J., Barkholt, L. & Ringden, O. (2004) A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation. Transplantation, 78, 1014-1020.
22. Little, M.-T. & Storb, R. (2002) History of haematopoietic stem-cell transplantation. Nature Reviews Cancer, 2, 231-238.
23. McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Radich, J., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensinger, W.I., Bryant, E., Flowers, M.E.D., Georges, G.E., Grumet, F.C., Kiem, H.-P., Torok-Storb, B., Yu, C., Blume, K.G. & Storb, R.F. (2001) Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood, 97, 3390-3400.
24. Mehta, J., Powles, R., Sirohi, B., Treleaven, J., Kulkarni, S., Saso, R., Tait, D. & Singhal, S. (2002) Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia? Bone Marrow Transplantation, 29, 853-859.
25. Mielcarek, M., Leisenring, W., Torok-Storb, B. & Storb, R. (2000) Graftversus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood, 96, 1150-1156.
26. Petersdorf, E.W., Gooley, T.A., Anasetti, C., Martin, P.J., Smith, A.G., Mickelson, E.M., Woolfrey, A.E. & Hansen, J.A. (1998) Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood, 92, 3515-3520.
27. Remberger, M., Watz, E., Ringden, O., Mattsson, J., Shanwell, A. & Wikman, A. (2007) Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 13, 675-682.
28. Resnick, I.B., Tsirigotis, P.D., Shapira, M.Y., Aker, M., Bitan, M., Samuel, S., Abdul-Hai, A., Ackerstein, A., Or, R. & Slavin, S. (2008) ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients. Biology of Blood and Marrow Transplantation, 14, 409-417.
29. Rowley, S.D., Liang, P.S. & Ulz, L. (2000) Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components. Bone Marrow Transplantation, 26, 749-757.
30. Seebach, J.D., Stussi, G., Passweg, J.R., Loberiza, Jr, F.R., Gajewski, J.L., Keating, A., Goerner, M., Rowlings, P.A., Tiberghien, P., Elfenbein, G.J., Gale, R.P., van Rood, J.J., Reddy, V., Gluckman, E., Bolwell, B.J., Klumpp, T.R., Horowitz, M.M., Ringden, O. & Barrett, A.J. (2005) ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biology of Blood and Marrow Transplantation, 11, 1006-1013.
31. Sorror, M.L., Maris, M.B., Storer, B., Sandmaier, B.M., Diaconescu, R., Flowers, C., Maloney, D.G. & Storb, R. (2004) Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplant comorbidities. Blood, 104, 961-968.
32. Stussi, G., Seebach, L., Muntwyler, J., Schanz, U., Gmur, J. & Seebach, J.D. (2001) Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a singlecentre experience. British Journal of Haematology, 113, 251-253.
33. Stussi, G., Muntwyler, J., Passweg, J.R., Seebach, L., Schanz, U., Gmur, J., Gratwohl, A. & Seebach, J.D. (2002) Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 30, 87-93.
34. Weissinger, F., Sandmaier, B.M., Maloney, D.G., Bensinger, W.I., Gooley, T. & Storb, R. (2001) Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. Blood, 98, 3584-3588.
35. Worel, N., Kalhs, P., Keil, F., Prinz, E., Moser, K., Schulenburg, A., Mitterbauer, M., Mannhalter, C., Mayr, W.R., Schwarzinger, I., Hocker, P., Lechner, K. & Greinix, H.T. (2003) ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion, 43, 1153-1161.
36. Zaucha, J.M., Mielcarek, M., Takatu, A., Little, M.-T., Gooley, T., Baker, J., Maloney, D.G., Sandmaier, B.M., Maris, M., Chauncey, T., Storb, R. & Torok-Storb, B. (2002) Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation. British Journal of Haematology, 119, 740-750.